The improvement in glycaemic status and IGF-1 level in diabetic rats treated with TDF-AgNPs may be due to antidiabetic and antioxidant effects of silver nanoparticles in the conjugates via scavenging the free radicals caused by TDF and diabetes [53,54]. The gene discussed is IGF1; the disease is diabetes mellitus.